source
- Industry wants more clarity on NGS for assessing gene therapy safetyThe pharmaceutical industry has largely endorsed the US Food and Drug Administration's (FDA) guidance on next-generation sequencing (NGS) for assessing the safety of human gene therapy products. Ho…raps · 15d ago↗ source
- This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and moreWelcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This wee…raps · 15d ago↗ source
- ‘Substantially better than before’: Why India has golden opportunity to build on innovative R&D winsA string of recent wins on the frontiers of novel drug development could mean that a homegrown innovation industry is within reach.